• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13D/A filed by Dominari Holdings Inc.

    6/13/24 8:56:04 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $DOMH alert in real time by email
    SC 13D/A 1 ea0207851-13da3wool_dominari.htm AMENDMENT NO. 3 TO SCHEDULE 13D

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13D

     

    Under the Securities Exchange Act of 1934

    (Amendment No. 3)*

     

      Dominari Holdings Inc.  
      (Name of Issuer)  
         
      Common Stock, par value $0.0001 per share  
      (Title of Class of Securities)  
         
      0088753043  
      (CUSIP Number)  
         
     

    Scott A. Mautner, Esq.

    Harrington Ocko & Monk, LLP

    81 Main Street, Suite 215

    White Plains, NY 10601

    (914) 686-4800

     
      (Name, Address and Telephone Number of Person Authorized to  
      Receive Notices and Communications)  
         
      June 11, 2024  
      (Date of Event Which Requires Filing of this Statement)  

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    SCHEDULE 13D

     

    CUSIP No. 0088753043

     

    1   

    NAME OF REPORTING PERSON

     

    Kyle Michael Wool

    2  

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a) ☐ (b) ☐
    3  

    SEC USE ONLY    

     

     

    4  

    SOURCE OF FUNDS  

     

    PF, OO

    5  

    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) 

     

    ☐
    6  

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States of America

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH REPORTING

    PERSON WITH

      7   

    SOLE VOTING POWER

     

    58,262 (1)

      8  

    SHARED VOTING POWER

     

    1,603,467 (1)

      9  

    SOLE DISPOSITIVE POWER

     

    58,262 (1)

      10  

    SHARED DISPOSITIVE POWER

     

    1,603,467 (1)

    11  

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,661,729

    12  

    CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E) 

     

     

    ☐ 
    13  

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

    26.36% (2)

    14  

    TYPE OF REPORTING PERSON

     

    IN

     

    (1)Of the 1,603,467 shares reported as beneficially owned with shared voting and dispositive power, 361,478 shares are beneficially owned directly by Mr. Wool and 1,241,989 shares are beneficially owned directly by Ms. Yu, Mr. Wool’s spouse. Of the 58,262 shares reported as beneficially owned with sole voting and dispositive power, 27,500 shares are held by Mr. Wool’s SEP-IRA, over which Mr. Wool has sole control, 24,000 shares are held by Mr. Wool’s Rollover IRA, over which Mr. Wool has sole control, 1,477 shares are held by Catatonk Creek, LLC, of which Mr. Wool is the sole member, 1,476 shares are held by Tioga 22, LLC, of which Mr. Wool is the sole member, and 3,559 shares are held in a UTMA account for the benefit of a minor relative.

     

    (2)Calculated based on 6,305,055 shares of Common Stock of the Issuer outstanding, which includes 5,995,065 shares of Common Stock outstanding as of May 7, 2024, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, and 154,995 shares of Common Stock issued to Mr. Wool and 154,995 shares of Common Stock issued to Mr. Anthony Hayes on June 11, 2024.

     

    2

     

     

    SCHEDULE 13D

     

    CUSIP No. 0088753043

     

    1   

    NAME OF REPORTING PERSON

     

    Soo Yu

    2  

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a) ☐

    (b) ☐

    3  

    SEC USE ONLY

     

     

    4  

    SOURCE OF FUNDS

     

    PF, OO

    5  

    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) 

     

    ☐
    6  

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States of America

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH REPORTING

    PERSON WITH

      7   

    SOLE VOTING POWER

     

    1,477 (1)

      8  

    SHARED VOTING POWER

     

    1,603,467 (1)

      9  

    SOLE DISPOSITIVE POWER

     

    1,477 (1)

      10  

    SHARED DISPOSITIVE POWER

     

    1,603,467 (1)

    11  

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,604,944

    12  

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

     

     

    ☐ 
    13  

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

    25.45% (2)

    14  

    TYPE OF REPORTING PERSON

     

    IN

     

    (1)Of the 1,603,467 shares reported as beneficially owned with shared voting and dispositive power, 1,241,989 shares are beneficially owned directly by Ms. Yu and 361,478 shares are beneficially owned directly by Mr. Wool, Ms. Yu’s spouse. The 1,477 shares reported as beneficially owned with sole voting and dispositive power are held by Dongam, LLC, of which Ms. Yu is the sole member.

     

    (2)Calculated based on 6,305,055 shares of Common Stock of the Issuer outstanding, which includes 5,995,065 shares of Common Stock outstanding as of May 7, 2024, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, and 154,995 shares of Common Stock issued to Mr. Wool and 154,995 shares of Common Stock issued to Mr. Anthony Hayes on June 11, 2024.

     

    3

     

     

    SCHEDULE 13D

     

    CUSIP No. 0088753043

     

    EXPLANATORY NOTE

     

    This Amendment No. 3 to Schedule 13D (this “Amendment No. 3”) is filed to amend the Schedule 13D (the “Initial Schedule 13D”) filed with the Securities and Exchange Commission on December 28, 2022 by Kyle Michael Wool and Soo Yu, as amended by Amendment No. 1 to Schedule 13D filed on July 6, 2023 (“Amendment No. 1”), as amended by Amendment No. 2 to Schedule 13D filed on December 28, 2023 (“Amendment No. 2” and collectively with the Initial Schedule 13D and Amendment No. 1, the “Schedule 13D”). This Amendment No. 3 supplements and amends the Schedule 13D as specifically set forth herein. Except as amended and supplemented by this Amendment No. 3, the Schedule 13D remains unchanged.

     

    Item 1. Security and Issuer.

     

    This statement on Schedule 13D relates to the common stock, $0.0001 par value per share (the “Common Stock”), of Dominari Holdings Inc., a Delaware corporation (the “Issuer”). The address of the Issuer’s principal executive offices is 725 5th Avenue, 22nd Floor, New York, New York 10022. 

     

    Item 2. Identity and Background.

     

    Paragraphs (a) through (c) of Item 2 of the Schedule 13D are hereby deleted in their entirety and replaced with the following:

     

    (a) This statement on Schedule 13D is being filed jointly by Kyle Michael Wool and Soo Yu as individuals, each of whom is referred to herein, together, as the “Reporting Persons.” The Reporting Persons are husband and wife.

     

    (b) The principal business address of the Reporting Persons is c/o Dominari Holdings Inc., 725 5th Avenue, 22nd Floor, New York, New York 10022.

     

    (c) Mr. Wool is President of the Issuer, Chief Executive Officer of Dominari Financial, Inc. (the Issuer’s financial services subsidiary) and Chief Executive Officer of Dominari Securities LLC (the Issuer’s broker-dealer subsidiary) (“Dominari Securities”). Each of Mr. Wool and Ms. Yu also serve as a director on the board of directors of the Issuer. On April 3, 2023, Ms. Yu entered into an Employment Agreement with Dominari Securities, as amended by the Amendment to Employment Agreement, dated as of April 19, 2023 (the “Employment Agreement”), to serve, initially, as a special projects manager and a registered brokerage representative of Dominari Securities, and she was subsequently promoted to Chief Operating Officer of Dominari Securities.

     

    Item 3. Source and Amount of Funds or Other Consideration.

     

    Item 3 of the Schedule 13D is hereby amended and supplemented with the following:

     

      ● On June 11, 2024, Mr. Wool was granted 154,559 shares of Common Stock of the Issuer by the Compensation Committee of the Issuer’s board of directors.

     

      ● Since Amendment No. 2 was filed on December 28, 2023, there was a net increase of (a) shares of Common Stock over which Ms. Yu has sole voting and dispositive power due to the purchase in open market transactions of an aggregate of 13,750 shares of Common Stock held by Ms. Yu’s pension; and (b) shares of Common Stock over which Mr. Wool has sole voting and dispositive power due to the purchase in open market transactions of an aggregate of 23,750 shares of Common Stock held by Mr. Wool’s SEP-IRA.

     

    Item 4. Purpose of Transaction.

     

    Item 4 of the Schedule 13D is hereby amended and supplemented with the following:

     

    Ms. Yu serves as the Chief Operating Officer of Dominari Securities. Pursuant to her Employment Agreement, Ms. Yu is entitled to receive a base salary of $150,000 per year and a 60% commission on the gross revenue she generates at Dominari Securities. The foregoing description of the Employment Agreement is qualified in its entirety by reference to the text of the Employment Agreement, which is attached hereto as Exhibit 1.01 and incorporated herein by reference.

     

    4

     

     

    SCHEDULE 13D

     

    CUSIP No. 0088753043

     

    The transaction giving rise to the filing of this Amendment No. 3 is the grant to Mr. Wool of 154,559 shares of Common Stock of the Issuer by the Compensation Committee of the Issuer’s board of directors.

     

    Except as disclosed in this Item 4, the Reporting Persons have no current plans or proposals which relate to or would result in any of the events described in Items (a) through (j) of the instructions to Item 4 of Schedule 13D. The Reporting Persons may, at any time and from time to time, review or reconsider their position and/or change their purpose.

     

    Item 5. Interest in Securities of the Issuer.

     

    (a)-(b)  The Reporting Persons have shared voting and dispositive power over 1,603,467 shares of Common Stock of the Issuer as a result of their status as husband and wife. Of the 1,603,467 shares of Common Stock that the Reporting Persons have shared voting and dispositive power over, 361,478 shares are beneficially owned directly by Mr. Wool and 1,241,989 shares are beneficially owned directly by Ms. Yu. In addition, Mr. Wool has sole voting and dispositive power over 58,262 shares of Common Stock, which he holds indirectly as follows: 27,750 shares are held by Mr. Wool’s SEP-IRA, over which Mr. Wool has sole control, 24,000 shares are held by Mr. Wool’s Rollover IRA, over which Mr. Wool has sole control, 1,477 shares are held by Catatonk Creek, LLC, of which Mr. Wool is the sole member, 1,476 shares are held by Tioga 22, LLC, of which Mr. Wool is the sole member, and 3,559 shares are held in a UTMA account for the benefit of a minor relative. Ms. Yu has sole voting and dispositive power over an additional 1,477 shares, which are held by Dongam, LLC, of which Ms. Yu is the sole member. Accordingly, on an individual basis, Mr. Wool and Ms. Yu beneficially own 26.36% and 25.45%, respectively, of the outstanding Common Stock of the Issuer. This is calculated based on 6,305,055 shares of Common Stock of the Issuer outstanding, which includes 5,995,065 shares of Common Stock of the Issuer outstanding as of May 7, 2024, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, and 154,995 shares of Common Stock issued to Mr. Wool and 154,995 shares of Common Stock issued to Mr. Anthony Hayes on June 11, 2024.

      

    (c) During the past sixty (60) days, an aggregate of 5,000 shares of Common Stock were purchased in open market transactions, which are beneficially owned indirectly by Mr. Wool as follows:

     

    Date of Purchase   Number of Shares   Price Per Share   Nature of Indirect Ownership
    05/29/2024   5,000   $2.20   By Mr. Wool’s SEP-IRA

     

    On June 11, 2024, Mr. Wool was granted 154,559 shares of Common Stock of the Issuer by the Compensation Committee of the Issuer’s board of directors.

     

    (d) None.

     

    (e) Not applicable.

      

    Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.

     

    The information provided or incorporated by reference in Items 2, 3, 4 and 5 of this Amendment No. 3, is hereby incorporated herein by this reference thereto.

     

    Item 7. Material to be Filed as Exhibits.

     

    Exhibit 1.01   Employment Agreement, made and entered into as of April 3, 2023, by and between Dominari Securities LLC and Soo Yu incorporated by reference to Exhibit 10.1 to the Issuer’s Quarterly Report on Form 10-Q (File No. 000-05576) filed on May 11, 2023.
    Exhibit 1.02   Amendment to Employment Agreement, made and entered into as of April 19, 2023, by and between Dominari Securities LLC and Soo Yu incorporated by reference to Exhibit 10.2 to the Issuer’s Quarterly Report on Form 10-Q (File No. 000-05576) filed on May 11, 2023.
    Exhibit 1.03   Joint Filing Agreement, dated as of June 13, 2024, between the Reporting Persons.

     

    5

     

     

    SCHEDULE 13D

     

    CUSIP No. 0088753043

     

    SIGNATURES

     

    After reasonable inquiry and to the best of each of the undersigned’s knowledge and belief, each of the undersigned certify that the information set forth in this statement is true, complete and correct.

     

    Dated: June 13, 2024

     

      /s/ Kyle Wool
      Kyle Wool
       
      /s/ Soo Yu
      Soo Yu

     

     

    6

     

    Get the next $DOMH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DOMH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DOMH
    Financials

    Live finance-specific insights

    See more
    • Dominari Holdings Investment, American Data Centers, Becomes American Bitcoin in Transformative Bitcoin Mining Deal with Hut 8

      Dominari Executing Expansion Strategy with Investment in Industrial Scale Bitcoin Mining and Bitcoin Reserve Development  NEW YORK, March 31, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) today announced that American Data Centers Inc. ("ADC") and Hut 8 Corp, ("Hut") partnered to form American Bitcoin Corporation.  As previously announced, ADC was a wholly owned subsidiary of Dominari, but became an independent company, whose members include Donald J. Trump Jr., Eric Trump, Dominari and other industry professionals in the AI space.  In partnership with Hut, American Bitcoin Corp., will focus on industrial-scale bitcoin mining and strategic bitcoin reserve development and monetiza

      3/31/25 8:00:00 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Securities Acquires Broker Team with $700 Million in Assets Under Management

      Firm Announces Five Day In Office Work Week NEW YORK, April 18, 2023 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) (the "Company") today announced that its wholly-owned subsidiary, Dominari Securities LLC, a FINRA licensed broker-dealer, has added an asset management team that manages over $700 million in client assets to its organization. This is the first significant acquisition since the division officially launched earlier this month after the purchase of the broker-dealer and registered investment adviser divisions of Fieldpoint Private Securities. Kyle Wool, CEO of Dominari Financial Inc. stated, "we are excited to have launched our broker-dealer division and are proudly open fo

      4/18/23 8:00:00 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Financial Inc. Acquires Leading Broker Dealer and Registered Investment Advisor Business

      Acquisition of Fieldpoint Private Securities Accelerates the Growth of the Company's Business with Launch of New Broker-Dealer and RIA Division NEW YORK, March 27, 2023 /PRNewswire/ -- Dominari Financial Inc., the financial services subsidiary of Dominari Holdings Inc., has announced the acquisition of the broker-dealer and registered investment advisor business of Fieldpoint Private Bank and Trust. The acquired business will be the foundation of a new financial services entity that will be known as Dominari Securities LLC. Fieldpoint Private Bank and Trust will continue to operate its Personal Banking and Commercial Banking entities under its name.

      3/27/23 5:35:00 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $DOMH
    SEC Filings

    See more
    • Dominari Holdings Inc. filed SEC Form 8-K: Leadership Update

      8-K - Dominari Holdings Inc. (0000012239) (Filer)

      5/23/25 4:15:22 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Dominari Holdings Inc. (0000012239) (Filer)

      5/13/25 8:15:21 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 10-Q filed by Dominari Holdings Inc.

      10-Q - Dominari Holdings Inc. (0000012239) (Filer)

      5/12/25 8:01:29 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $DOMH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CEO Hayes Anthony gifted 15,000 shares, decreasing direct ownership by 0.92% to 1,614,566 units (SEC Form 4)

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      5/6/25 4:15:04 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by President Wool Kyle Michael

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      4/16/25 7:55:12 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by CEO Hayes Anthony

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      4/16/25 7:54:31 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $DOMH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Dominari Holdings Inc.

      SC 13D/A - Dominari Holdings Inc. (0000012239) (Subject)

      6/13/24 8:56:04 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SC 13D/A filed by Dominari Holdings Inc.

      SC 13D/A - Dominari Holdings Inc. (0000012239) (Subject)

      6/13/24 4:32:07 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $DOMH
    Leadership Updates

    Live Leadership Updates

    See more
    • Dominari Holdings Inc. Strengthens Team with Appointment of Experienced Accounting Team

      Edward Deignan Appointed as VP of Finance and Accounting Kyle Degruttola Appointed as Controller NEW YORK, NY / ACCESSWIRE / November 11, 2024 / Dominari Holdings Inc. (NASDAQ:DOMH) (the "Company") today announced that it has appointed Edward Deignan as Vice President of Finance and Accounting and Kyle Degruttola as Controller. Together, they bring decades of accounting and finance leadership experience from various multi-national and public sector organizations.Mr. Deignan is responsible for the day-to-day management of the Company's financial operations. He brings with him more than 30 years of experience in accounting, finance and banking. He has served as a chief financial officer for s

      11/11/24 8:00:00 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Securities LLC Announces Appointment of Capital Markets Veteran James Hopkins as Managing Director Head of Capital Markets

      Hopkins has Led and Structured Hundreds of Capital Markets Transactions NEW YORK, NY / ACCESSWIRE / October 7, 2024 / Dominari Holdings Inc. (NASDAQ:DOMH) (the "Company") today noted that its wholly-owned subsidiary, Dominari Securities LLC ("Dominari"), announced that it has further expanded its practice with the appointment of capital markets veteran James (Jimmy) Hopkins as Managing Director Head of Capital Markets.Mr. Kyle Wool, CEO of Dominari Securities LLC, commented, "Our commitment to positioning Dominari as a full-service, diversified financial services firm and growing our business remains stronger than ever, and Jimmy has a proven record of success with hundreds of completed tran

      10/7/24 8:00:00 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Securities Appoints 30 Year Financial Industry Expert to Manage Operations and Compliance

      Eric Newman Appointed as Executive Vice President  NEW YORK, March 15, 2024 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) (the "Company") today announced its wholly-owned subsidiary, Dominari Securities LLC, has appointed financial industry veteran, Eric Newman, to the role of Executive Vice President of Dominari Securities enriching the firm's investment banking expertise and bolstering its brokerage operations. Mr. Newman reports directly to CEO Kyle Wool and is responsible for managing the day-to-day aspects of the firm's broker-dealer operations, advising executive

      3/15/24 8:30:00 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $DOMH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Dominari Holding's Strategic Interest in Bitcoin Mining Set to Go Public

      American Bitcoin Enters into Definitive Merger Agreement with Nasdaq-listed Gryphon Digital Mining to Build World's Largest, Most Efficient Pure-Play Bitcoin Minor Alongside A Robust and Strategic Bitcoin Reserve NEW YORK, May 13, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH), today congratulates American Bitcoin on entering into a definitive merger agreement with Gryphon Digital Mining, Inc. (NASDAQ:GRYP). The strategic stock-for-stock transaction will result in American Bitcoin becoming a publicly traded entity on Nasdaq in which former American Bitcoin stockholders, including Dominari Holdings, will own approximately 98% of the combined company.

      5/13/25 8:00:00 AM ET
      $DOMH
      $GRYP
      Biotechnology: Pharmaceutical Preparations
      Health Care
      EDP Services
      Technology
    • authID Announces Pricing of Approximately $8,150,000 Million Registered Direct Offering

      DENVER, March 31, 2025 (GLOBE NEWSWIRE) -- authID Inc. (NASDAQ:AUID) ("authID" or the "Company"), a leading provider of biometric identity verification and authentication solutions, today announced it has entered into a definitive agreement with investors to sell approximately 1,811,111 shares  of its common stock (the "Shares") and/or Pre-Funded Warrants (the "Pre-Funded Warrants"), pursuant to a registered direct offering (the "Registered Direct Offering"). The purchase price for one Share or Pre-Funded Warrant will be $4.50, (each Pre-Funded Warrant will be exercisable into one share of common stock). The aggregate gross proceeds from the Offering are expected to be approximately $8,15

      3/31/25 8:30:00 AM ET
      $AUID
      $DJT
      $DOMH
      $DWAC
      Computer Software: Prepackaged Software
      Technology
      Computer Software: Programming Data Processing
      Biotechnology: Pharmaceutical Preparations
    • Dominari Holdings Investment, American Data Centers, Becomes American Bitcoin in Transformative Bitcoin Mining Deal with Hut 8

      Dominari Executing Expansion Strategy with Investment in Industrial Scale Bitcoin Mining and Bitcoin Reserve Development  NEW YORK, March 31, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) today announced that American Data Centers Inc. ("ADC") and Hut 8 Corp, ("Hut") partnered to form American Bitcoin Corporation.  As previously announced, ADC was a wholly owned subsidiary of Dominari, but became an independent company, whose members include Donald J. Trump Jr., Eric Trump, Dominari and other industry professionals in the AI space.  In partnership with Hut, American Bitcoin Corp., will focus on industrial-scale bitcoin mining and strategic bitcoin reserve development and monetiza

      3/31/25 8:00:00 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $DOMH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Ledwick Tim S bought 8,645 shares and was granted 10,000 shares, increasing direct ownership by 145% to 31,471 units (SEC Form 4)

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      2/12/25 5:03:10 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Lieberman Ronald J. bought 21,613 shares and was granted 10,000 shares (SEC Form 4)

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      2/12/25 5:00:46 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • President Wool Kyle Michael bought 288,184 shares, increasing direct ownership by 15% to 2,200,769 units (SEC Form 4)

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      2/12/25 4:58:43 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care